Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities

To explore, on a genome-wide scale genomic, epigenomic, bulk and single-cell transcriptomic regulatory network of ARID1A in gastric cancer to enable a better understanding of the mechanism underlying its high alteration prevalence in GC.